申请人:Boehringer Ingelheim Pharma KG
公开号:US06043254A1
公开(公告)日:2000-03-28
The present invention relates to indolinones of general formula ##STR1## wherein R.sub.1 to R.sub.3 are defined in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
本发明涉及一般式##STR1##中R.sub.1至R.sub.3的定义如权利要求1所述,其异构体和盐,特别是具有有价值的药理特性的生理上可接受的盐,特别是对各种激酶和cycline/CDK复合物以及各种肿瘤细胞增殖具有抑制作用的盐,含有这些化合物的药物组合物,它们的用途和制备它们的方法。